Galan receives promising early stage lithium brine results from Candelas

|

Published 29-MAY-2019 12:22 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Galan Lithium Limited (ASX:GLN) has received initial assays from its fifth drill hole at the Candelas lithium brine project located in Catamarca province, Argentina.

The drill hole is located approximately 2.5 kilometres south of the maiden drill hole which provided outstanding results, including an intercept of 192 metres at 802 mg/l Li with low impurities.

Laboratory results for the fifth hole indicate robust lithium grades from the brine horizon from 220 metres to 380 metres, ranging from 491 mg/l to 856 mg/l.

Impurity levels continue to return low values with Mg:Li of approximately 2.6, similar to those observed at the nearby Livent’s (NYSE:Fenix) and Galaxy Resources’ (ASX:GXY) Sal de Vida operations.

Keeping up with the neighbours

As a backdrop, Galan is exploring for lithium brines within South America’s Lithium Triangle on the Hombre Muerto salar in Argentina.

Hombre Muerto is proven to host the highest grade and lowest impurity levels within Argentina and is home to Livent Corporation’s El Fenix operation and Galaxy Resources and POSCO’s Sal de Vida projects.

Galan’s primary target is the adjoining Candelas channel target, a wide valley filled channel approximately 15 kilometres long and between three and five kilometres wide.

Recent geophysics and drilling indicate the potential for this target to host a substantial volume of brine.

Heavy wintry weather has recently delayed operations and final sampling onsite from the fifth hole, and as such further information regarding the remainder of testing could yield even better results.

However, as we previously highlighted and as illustrated below, lab results to date point to further promising news as they indicate good lithium grades from the brine horizon from 220 metres to 380 metres, ranging from 491 to 856 mg/l lithium.

Hole six data could be another catalyst

Drillhole C-06-19 was also recently completed to a depth of 422 metres after encountering basement at 419 metres.

Field results conducted before operations had to cease encountered brines with SG ranging from 1.09 to 1.13 for the last 42 metres of the hole, with the higher SG met at the top of the 42 metres section.

Upon re-commencement of operations, sampling will be completed on the fifth hole and new ascending tests will be performed on the sixth hole to delineate the brine horizon and its total thickness.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X